MoneyWorks4Me

Jubilant Pharmova - Quaterly Results

02 Aug 2022 Evaluate
The revenue zoomed 14.52% to Rs. 2045.70 millions for the quarter ended June 2022 as compared to Rs. 1786.40 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2022 is Rs. -51.80 millions as compared to Net Loss of Rs. -7.60 millions of corresponding quarter ended June 2021A decline of 58.70 millions was observed in the OP in the quarter ended June 2022 from 108.40 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 2045.70 1786.40 14.52 2045.70 1786.40 14.52 877.50 27095.00 -96.76
Other Income 102.40 42.80 139.25 102.40 42.80 139.25 1258.70 478.80 162.89
PBIDT 58.70 108.40 -45.85 58.70 108.40 -45.85 1190.90 4749.40 -74.93
Interest 31.50 26.70 17.98 31.50 26.70 17.98 305.90 1018.00 -69.95
PBDT 27.20 81.70 -66.71 27.20 81.70 -66.71 885.00 3731.40 -76.28
Depreciation 92.10 91.60 0.55 92.10 91.60 0.55 62.50 999.70 -93.75
PBT -64.90 -9.90 555.56 -64.90 -9.90 555.56 822.50 2731.70 -69.89
TAX -13.10 -2.30 469.57 -13.10 -2.30 469.57 37.50 586.90 -93.61
Deferred Tax -13.10 -3.20 309.38 -13.10 -3.20 309.38 -99.10 132.50 -174.79
PAT -51.80 -7.60 581.58 -51.80 -7.60 581.58 785.00 2144.80 -63.40
Equity 159.30 159.30 0.00 159.30 159.30 0.00 159.30 159.30 0.00
PBIDTM(%) 2.87 6.07 -52.71 2.87 6.07 -52.71 135.72 17.53 674.25
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..